Microplastics larger than 20 µm appear to be routinely present in commercially available eye drops, according to research published in Cornea. The investigation employed the use of micro-Fourier ...

Krystal Biotech announced the first patient has been dosed in EMERALD-1, its phase 1/2 clinical trial evaluating KB801 for ...